|
|
Volumn 20, Issue 3, 2014, Pages 231-
|
|
Engage with research participants about social media
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CENTRAL NERVOUS SYSTEM AGENTS;
DEXPRAMIPEXOLE;
FINGOLIMOD;
LITHIUM CARBONATE;
NP 001;
SODIUM CHLORITE;
TELAPREVIR;
UNCLASSIFIED DRUG;
CONVERSATION;
DRUG APPROVAL;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
EMPOWERMENT;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ORGANIZATION;
HUMAN;
INFORMED CONSENT;
MEDICAL DECISION MAKING;
MEDICAL INFORMATION;
MEDICAL RESEARCH;
MULTIPLE SCLEROSIS;
NOTE;
PHYSICIAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESEARCH SUBJECT;
RISK BENEFIT ANALYSIS;
SOCIAL MEDIA;
SYMPTOM;
CLINICAL TRIALS AS TOPIC;
COMMUNICATION;
CONFIDENTIALITY;
DRUG INDUSTRY;
HUMANS;
INTERNET;
PATIENT PARTICIPATION;
PATIENT SAFETY;
PATIENT SELECTION;
RESEARCH DESIGN;
SOCIAL MEDIA;
|
|
EID: 84896119461
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0314-231 Document Type: Note |
|
Times cited : (18)
|
|
References (3)
|
